-
Zuckerberg skewered again on screen in 'The Social Reckoning'
-
Big guns back for Australia's Rugby League World Cup defence
-
Fiji urges 'just' climate transition, financing at pre-COP gathering
-
Braves rock Dodgers to level series, Brewers win thriller
-
Thailand's Jeeno overcomes late wobble to win Lotte Championship
-
Most Asia stocks rally as 'Goldilocks' jobs data ease rate fears
-
Brazil heads to run-off as Bolsonaro pulls off shock first place finish over Lula
-
Sunken Silk Road city reveals Central Asia's lost history
-
EU, China to hold Beijing talks to avert trade war
-
Three years on, Israeli rescuer cannot escape October 7
-
Bolsonaro edges past Lula as nail-biter Brazil vote goes to a run-off
-
Research into weight-loss drugs tipped for Nobel as award week opens
-
Rubio visits Iceland as US boosts Arctic presence
-
US Supreme Court hears bid to shut the door on climate suits
-
Bolsonaro leads Lula as nail-biter Brazil vote goes to a run-off
-
Chourio walk-off single lifts Brewers over Padres
-
Patriots inflict first Bills defeat as Chiefs keep winning
-
Fulcrum Metals PLC Announces Pilot site & Pilot Technology Agreement Secured
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 05
-
Flavio Bolsonaro leads Lula in near-done Brazil vote count
-
Pacific nations take centre stage at 'pre-COP' climate summit
-
Flavio Bolsonaro leads Lula in partial Brazil poll results
-
Ronaldo can return to Portugal team if he wants: coach Jesus
-
Titan FX Launches Second “Dream Beyond Borders 2.0” Brand Commercial Featuring Keisuke Honda
-
Portugal move into Nations League knockout stage, Germany held
-
Patriots inflict first Bills defeat as Rams surge late
-
Ronaldo-less Portugal beat Norway to reach Nations League quarters
-
Brazil's Indigenous back Lula as El Nino fuels forest fires
-
Bosnian Serb strongman claims election win, thanks Trump and Putin
-
Brazil braces for results of election battle between Lula and Bolsonaro
-
Israel wear black armbands in Ireland tie over Hamas attack
-
Indians protest election chief ahead of top court hearing
-
'I fear it could drag on': anxiety takes hold in Ethiopian city wrested from rebels
-
'Verity' kills, Cruise bombs in N. American movie theaters
-
Brazil's Lula and Flavio Bolsonaro face off in knife-edge election
-
Colts top Commanders in NFL London game
-
UK Green party adopts 'Zionism is racism' policy
-
Hundreds of schools to shut Monday as student protests rock France
-
Rio favela residents vote with little hope
-
Three previous two-time Arc de Triomphe winners
-
Evenepoel puts worlds 'disappointment' to bed with European crown
-
'Champion' Daryz wins second successive Arc in fine style
-
Two-time winning Arc trainer Rouget bows out in emotional farewell
-
Daryz wins second successive Prix de l'Arc de Triomphe
-
Battling Djokovic stuns top seed Zverev at China Open
-
England's seven-goal spree sends message to Euro rivals: Kane
-
Spy chief Clayton, the Trump loyalist tech bosses trust on AI
-
Trump confirms national intelligence chief as new AI czar
-
UK's Glastonbury festival tickets sell out in 45 minutes
-
Up to 500 French schools to be totally or partly closed Monday: minister
Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids"
SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem cell biologist Hiromitsu Nakauchi. The support is directed primarily at the lab's work on bodyoids.
The concept reached a wide audience in March 2025, when Nakauchi and co-authors Carsten Charlesworth and Henry Greely laid it out in MIT Technology Review under the title "Ethically sourced 'spare' human bodies could revolutionize medicine." Bodyoids, as the authors described them, would be human bodies grown from pluripotent stem cells entirely outside a human body, and developed in a way that precludes sentience.
The case they made was one of scarcity. More than 100,000 patients in the United States alone are waiting for an organ transplant. Fewer than 15% of drugs entering clinical trials ever reach regulatory approval, in large part because animal models are poor proxies for human physiology. Bodyoids would, in principle, address both bottlenecks at once: a potentially unlimited supply of immunologically matched organs and tissues, and a genuinely human substrate on which to test drugs before they reach patients.
The science required remains years away, and the questions it raises will need to be worked through carefully and in public. Wang said that is an argument for funding the work early rather than late.
"Replacement is one of the central themes of our investment thesis," said Boyang Wang. "If research directions like bodyoids succeed, they offer a very good answer to problems the whole world shares, starting with organ shortage. That is why we are willing to support underfunded areas and help push scientific breakthroughs forward."
The Nakauchi Lab sponsorship is one of several research commitments Immortal Dragons has made in aging and neurodegeneration. The fund also supports Andy Tsai, a researcher in the Tony Wyss-Coray Lab and a director of the Sundial Initiative, whose work focuses on brain resilience mechanisms.
About Immortal Dragons
Immortal Dragons is a purpose-driven longevity fund headquartered in Singapore. The fund invests in cutting-edge, high-impact technologies and currently supports more than 15 portfolio companies. Beyond conventional investments, the fund advances longevity advocacy through book translation and publishing, translation of longevity leaders' talks, hosting a leading Chinese-language longevity podcast, and providing sponsorships and grants to longevity initiatives and conferences.
About the Sundial Initiative
Sundial Initiative is a California nonprofit building scientific infrastructure at the intersection of biological aging, human resilience genetics, and real-world lifestyle data.
For Press Inquiries
Boyang Wang
Founder, Immortal Dragons
[email protected]
SOURCE: Immortal Dragons
View the original press release on ACCESS Newswire
L.Harper--AMWN